Related Experiment Video
Updated: Sep 11, 2025
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
Unlocking the full potential of piperine-loaded nanocarriers for cancer treatment
Girish Kumar1, Beatriz Ruivinho2,3, Tarun Virmani1
1Amity Institute of Pharmacy, Amity University, Greater Noida, India.
Abstract:
In the twenty-first century, cancer continues to be a significant worldwide health concern that requires immediate and ongoing attention. Currently, chemotherapeutic treatments are constrained by various limitations, including drug resistance, nonspecific distribution, and organ toxicity. These difficulties highlight the need for safer and more efficient substitutes, like Piperine (PPN), a bioactive alkaloid obtained from Piper longum and Piper nigrum, as a viable option for cancer therapy. The diverse pharmacological characteristics of PPN, such as anti-inflammatory, antioxidant, and anticancer, make it an intriguing natural substance. However, the poor aqueous solubility, low penetration, and poor pharmacokinetic behaviors of PPNs impede its clinical translation. The design of nanoformulations of PPNs can be a promising approach to overcome its limitations, improving therapeutic effectiveness and bioavailability, while facilitating targeted delivery and synergistic effect toward cancer therapy. The current review provides an in-depth overview of the latest developments in PPN-based nanoformulations, highlighting their potential to address persistent problems in cancer treatment and pave the way for their integration into clinical oncology.
Insights
Piperine (PPN) shows promise for cancer therapy, but its effectiveness is limited by poor solubility and pharmacokinetics. Nanoformulations of PPN can overcome these challenges, enhancing its potential for clinical oncology.
Area of Science:
- Oncology
- Pharmacology
- Nanotechnology
Background:
- Cancer remains a major global health challenge.
- Current chemotherapy faces limitations like drug resistance and toxicity.
- Piperine (PPN), a natural alkaloid, exhibits anticancer properties but has poor bioavailability.
Purpose of the Study:
- To review advancements in Piperine (PPN)-based nanoformulations for cancer therapy.
- To explore how nanoformulations can overcome PPN's limitations.
- To highlight the potential of PPN nanoformulations in clinical oncology.
Main Methods:
- Review of current literature on Piperine (PPN) and its nanoformulations.
- Analysis of studies focusing on PPN's pharmacological properties.
- Evaluation of nanoformulation strategies to improve PPN's solubility, penetration, and pharmacokinetics.
Main Results:
- Nanoformulations significantly enhance Piperine's (PPN) aqueous solubility and bioavailability.
- Targeted delivery and synergistic effects are improved with PPN nanoformulations.
- PPN nanoformulations demonstrate potential in overcoming limitations of conventional cancer treatments.
Conclusions:
- Piperine (PPN) nanoformulations offer a promising strategy to improve cancer therapy.
- These nanoformulations can enhance therapeutic efficacy and reduce toxicity.
- Further research into PPN nanoformulations could lead to clinical integration in oncology.
